Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Cryo-Cell International, Inc. (CCEL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.23-0.22 (-3.41%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.45
Open6.42
Bid6.05 x 4000
Ask6.45 x 1000
Day's Range6.23 - 6.43
52 Week Range6.00 - 14.16
Volume449
Avg. Volume6,530
Market Cap53.14M
Beta (5Y Monthly)0.47
PE Ratio (TTM)12.98
EPS (TTM)0.48
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

    OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2022. Financial Results Revenue The revenues for the first quarter of fiscal 2022 were $7.26 million compared to $6.86 million for the first quarter of fiscal 2021. The revenues for the first quarter of fiscal 2022 co

  • GlobeNewswire

    Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

    OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announces it has entered into a purchase contract, with the closing subject to customary conditions, for a newly constructed, 56,000 sq ft facility located in the Regional Commerce Center within the Research Triangle, NC. We anticipate this facility will expand Cryo-Cell’s cryopr

  • GlobeNewswire

    Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

    Cryo-Cell Institute for Cellular Therapies Cryo-Cell Institute for Cellular Therapies OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, has released its 2021 Annual Letter to Cryo-Cell Shareholders as shown below. February 22, 2022 Dear Fellow Cryo-Cell Shareholders, Overview I am very proud of the progress that Cryo-Cell Intern

Advertisement
Advertisement